Skip to Main Content

Paper Details

Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial.
Clin Cancer Res
59
2019
Author NameAffiliation
Zhiyong WangUniversity of California San Diego (university of california san diego) Moores Cancer Center
Xingyu WuUniversity of California San Diego (university of california san diego) Moores Cancer Center
Olivier HarismendyUniversity of California San Diego (university of california san diego) Moores Cancer Center
Alfredo A MolinoloNational Institute of Dental and Craniofacial Research
Alfredo A MolinoloUniversity of California San Diego (university of california san diego) Moores Cancer Center
Alfredo A MolinoloNational Institute of Dental and Craniofacial Research
Alfredo A MolinoloUniversity of California San Diego (university of california san diego) Moores Cancer Center
Scott M LippmanUniversity of California San Diego (university of california san diego) Moores Cancer Center
Carter Van WaesNational Institute on Deafness and Other Communication Disorders
Carter Van WaesNational Institute on Deafness and Other Communication Disorders
Jorge Silvio GutkindNational Institute of Dental and Craniofacial Research
Jorge Silvio GutkindUniversity of California San Diego (university of california san diego) Moores Cancer Center
  • 1 - 12

Datasets